Analyst Coverage Change
On Tuesday January 24th, Morgan Stanley(Rank#1) issued a research report on Gilead Sciences, maintaining the Equal Weight rating on the stock, and lowering the target to $80 from $81 per share.
Gilead Stock Forecast & Analysis
Gilead Sciences Inc is a company that is currently being analyzed by 17 different analysts. These analysts have made stock price forecasts for the company, and on average, they predict that the stock price will be around USD 81.33 over the next 12 months. Additionally, the average analyst rating for the company is “Buy”, which suggests that these analysts believe that the stock is a good investment opportunity.
Stock Target Advisor’s analysis of the company is “Slightly Bullish”, which is based on 9 positive signals and 6 negative signals.
The current stock price of Gilead Sciences Inc is USD 83.23, which is slightly higher than the average analyst target price. Over the past week, the stock price has decreased by -3.52%, over the past month it has decreased by -1.79%, but over the last year, it has increased by +21.49%.
Gilead Sciences, Inc. is a publicly traded company listed on the Nasdaq stock exchange under the ticker symbol GILD. The company has announced that it will be releasing its financial results for the fourth quarter and full year of 2022, as well as providing full year 2023 financial guidance on Thursday, February 2nd. This information will be made available to the public after the stock market closes for the day.
In addition to releasing the financial information, Gilead Sciences’ management will also host a webcast to discuss the results and provide an update on the company’s business. The webcast will take place at 4:30 p.m. Eastern Time on February 2nd. This is an opportunity for investors, analysts and other interested parties to hear from the company’s management team about the financial performance of the company and what to expect in the future.
This financial release and webcast is important for investors and analysts as it will give them insight into the company’s financial performance and help them make informed decisions about the company’s stock.